Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study
Julie Helms, François Severac, Hamid Merdji, Maleka Schenck, Raphaël Clere-Jehl, Mathieu Baldacini, Mickaël Ohana, Lélia Grunebaum, Vincent Castelain, Eduardo Anglés-Cano, Laurent Sattler, Ferhat Meziani, for the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care
Sepsis Trial Group for Global EvaluationResearch in Sepsis);Julie Helms;François Severac;Hamid Merdji;Maleka Schenck;Raphaël Clere-Jehl;Mathieu Baldacini;Mickaël Ohana;Lélia Grunebaum;Vincent Castelain;Eduardo Anglés-Cano;Laurent Sattler;Ferhat Meziani;for the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care
Sepsis Trial Group for Global EvaluationResearch in Sepsis);
annals of intensive care2021Vol. 11pp. -
122
sepsis)2021annalshigher
Abstract
Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or therapeutic dosage ...